1
Ma T, Wang Y, Huang C, Zhang X, An Y, Zhang Q, Kong Q, Cao B. Chimeric hBPI23-Fcγ protein shows bactericidal activity against drug-resistant Gram-negative bacteria and protects mice from lethal challenge. Arch Microbiol. 2025 Mar 28;207(5):103. doi: 10.1007/s00203-025-04306-2. PMID: 40152989.
2
Cao W#, Su W#, Song X#, Ma L#, Li Y#, Yan H, Li J, Yang J, Zhao J, Liu K, Qiu R, He G, Shi F, Wang J, Suo L, Liu X, Zhang Y, Li L, Zhao H, Li T, Yi G, Huang Z, Gao S, Wang Y*, Cao B*. Efficacy and Safety of WXSH0208 Tablets in Treatment of Acute Uncomplicated Influenza Infection in Adults: A Multicenter Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial. J Infect Dis. 2025 Mar 25:jiaf075. doi: 10.1093/infdis/jiaf075. Epub ahead of print. PMID: 40131019.
3
Zhang R#, Yu J, Shang X, Wang Z, Li H*, Cao B*. Heterogeneity in clinical patterns of adult lung abscess patients: an 8-year retrospective study in a tertiary hospital. BMC Pulm Med. 2025 Mar 5;25(1):101. doi: 10.1186/s12890-025-03487-2. PMID: 40045326;
4
Yan Y#, Shang L#, Xu J, Gu X, Fan G, Wang Y, Cao B*. The prevalence and outcomes of viremia in patients with acute respiratory viral infection: a systematic review and meta-analysis. Clin Microbiol Infect. 2025 Jan 28:S1198-743X(25)00035-7. doi: 10.1016/j.cmi.2025.01.027. Epub ahead of print. PMID: 39884502.
5
Yan M#, Shang L#, Wang Y#, Wang C, Cao B*. Metagenomic next-generation sequencing on treatment strategies and prognosis of patients with lower respiratory tract infections: A systematic review and meta-analysis. Int J Antimicrob Agents. 2025 Jan 4;65(3):107440. doi: 10.1016/j.ijantimicag.2024.107440. Epub ahead of print. PMID: 39761759.
6
Zhuo X#, Lei Z, Pu D, Wu Y, Zhao J*, Cao B*. Hypervirulent Klebsiella pneumoniae have better clinical outcomes than classical Klebsiella pneumoniae for lower respiratory tract infection patients. BMC Microbiol. 2025 Jan 22;25(1):40. doi: 10.1186/s12866-024-03726-2. PMID: 39844054; PMCID: PMC11753108.
7
Wang Y#, Wang H#, Zhang Y#, Ma A#, Liu D#, Li X, Yang G, Deng M, Wang S, Liu Y, Liu C, Ge F, Wang S, Yu Y, Feng G, Xiao Z, Li X, Sun Y, Chen X, Cao Z, Ding Y, Wu X, Wei J, Cao B*. Single-dose suraxavir marboxil for acute uncomplicated influenza in adults and adolescents: a multicenter, randomized, double-blind, placebo-controlled phase 3 trial. Nat Med. 2025 Jan 7. doi: 10.1038/s41591-024-03419-3.
